Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice

Gut

Volumn 41, Issue 5, 1997, Pages 636-641

  Komatsu, S ^a   Grisham, M B ^a   Russell, J M ^a   Granger, D N ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Aminoguanidine; C kit; Dexamethasone; Epithelium; Neutrophils

Indexed keywords

AMINOGUANIDINE; DEXAMETHASONE; EDETATE CHROMIUM CR 51; LODOXAMIDE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030720797     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.5.636     Document Type: Article

References (17)

1. Brown JF, Tepperman BL, Hanson PJ, Whittle BJR, Moncada S. Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun 1992; 184: 680-5.
2. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane JR. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol 1991; 17 (suppl 3): S258-64.
3. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-5.
4. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson JC, Miyasaka M, et al. Inhibition of nitric oxide production: mechanism of vascular albumin leakage. Circ Res 1993; 73: 164-71.
5. Kurose I, Wolf R, Grisham MB, Granger DN. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol 1995; 268: H2224-31.
6. Kubes P. Ischemia/reperfusion in the feline small intestine: a role for nitric oxide. Am J Physiol (Gastrointest Liver Physiol) 1993; 264: G143-9.
7. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994; 74: 376-82.
8. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol (Gastrointest Liver Physiol) 1996; 270: G225-37.
9. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992; 262: G1138-42.
10. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G222-9.
11. Pothoulakis C, Karmeli F, Kelly CP, Eliakim R, Joshi MA, O'Keane CJ, et al. Ketotifen inhibits clostridium difficile toxin A induced enteritis in rat ileum. Gastroenterology 1993; 105: 701-7.
12. v mice and their increase by bone marrow transplantation. Blood 1978; 52: 447-52.
13. sh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood 1992; 80: 1448-53.
14. Crissinger K, P R Kvietys, Granger D N. Pathophysiology of gastrointestinal mucosal permeability. J Intern Med 1990; 228 (suppl 1): 145-54.
15. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41: 552-6.
16. Griffiths MJD, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectivity inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110: 963-8.
17. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-25.